SCHEMBL6801553

SCHEMBL6801553

C=CC[C@H](C(=O)O)[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 17/20 0.63
MMP2 P08253 16/20 0.63
MMP7 P09237 14/20 0.63
MMP1 P03956 14/20 0.62
MMP8 P22894 2/20 0.62
MMP9 P14780 2/20 0.62
ADAM17 P78536 1/20 0.62
MMP12 P39900 1/20 0.62
MMP13 P45452 1/20 0.62
MMP14 P50281 1/20 0.62
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
ATM Q13315 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
REN P00797 1/20 0.48
FCER2 P06734 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4423322 0.92 MMP2 (0.75) MMP3MMP2MMP7MMP1MMP8
SCHEMBL6808424 0.91 MMP2 (0.62) MMP3MMP2MMP7MMP1MMP8
SCHEMBL7651206 0.90 MMP2 (0.67) MMP3MMP2MMP7MMP1MMP8
SCHEMBL7651203 0.90 MMP2 (0.67) MMP3MMP2MMP7MMP1MMP8
SCHEMBL6803244 0.90 MMP2 (0.67) MMP3MMP2MMP7MMP1MMP8
SCHEMBL6802524 0.89 MMP2 (0.60) MMP3MMP2MMP7MMP1MMP8
SCHEMBL6804212 0.89 MMP2 (0.60) MMP3MMP2MMP7MMP1MMP8
SCHEMBL6797912 0.88 MMP2 (0.65) MMP3MMP2MMP7MMP1MMP8
SCHEMBL6804731 0.88 MMP2 (0.66) MMP3MMP2MMP7MMP1MMP8
SCHEMBL7376771 0.87 MMP2 (0.72) MMP3MMP2MMP7MMP1MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6790834-B1 Cytostatic agents BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2004-09-14 US disclosed
US-6462023-B1 SUCH AS 2-HYDROXY-HYDROXYCARBAMOYL-METHYL)-4-METHYL-PENTANOYLAMINE)-2-PHENYL -ETHANOIC ACID CYCLOPENTYL ESTER; INHIBITING HYPERPROLIFERATIVE TUMOURGENIC CELLS SUCH AS MELANOMA AND/OR LYMPHOMA CELLS BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2002-10-08 US disclosed
EP-0925278-B1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARM (GB) 2002-07-17 EP disclosed
US-6169075-B1 ANTITUMOR AGENT INHIBITING THE PROLIFERATION OF A RANGE OF RAPIDLY DIVIDING TUMOUR CELLS LIKE MELANOMA AND/OR LYMPHOMA CELLS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2001-01-02 US disclosed
EP-0925278-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-06-30 EP disclosed
WO-1998011063-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-03-19 WO disclosed